Compounds > vadimezan
Page last updated: 2024-09-03

vadimezan and 4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide

vadimezan has been researched along with 4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide in 1 studies

Compound Research Comparison

Studies
(vadimezan)		Trials
(vadimezan)		Recent Studies (post-2010)
(vadimezan)		Studies
(4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide)		Trials
(4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide)		Recent Studies (post-2010) (4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide)
2721610124022

Protein Interaction Comparison

ProteinTaxonomyvadimezan (IC50)4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide (IC50)
Histone deacetylase 3Homo sapiens (human)4.2196
Cytochrome P450 2D6Homo sapiens (human)3.02
Cytochrome P450 2C19Homo sapiens (human)3.02
Histone deacetylase 4Homo sapiens (human)9.39
Histone deacetylase 1Homo sapiens (human)1.5097
Histone deacetylase 7Homo sapiens (human)3.445
Histone deacetylase 2Homo sapiens (human)5.259
Polyamine deacetylase HDAC10Homo sapiens (human)3.9353
Histone deacetylase 11 Homo sapiens (human)5.14
Histone deacetylase 8Homo sapiens (human)1.0848
Histone deacetylase 6Homo sapiens (human)0.1536
Histone deacetylase 9Homo sapiens (human)4.36
Histone deacetylase 5Homo sapiens (human)6.62

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for vadimezan and 4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023